HCA Holdings Inc is a leading healthcare company that operates a vast network of hospitals and outpatient facilities across the United States and the United Kingdom. The organization focuses on delivering high-quality medical services, particularly in emergency care, surgical procedures, and specialized treatments. By integrating advanced technology and a skilled workforce, HCA aims to enhance patient experiences and outcomes while maintaining operational efficiency. Additionally, the company emphasizes community engagement and philanthropic efforts to improve healthcare access and foster wellness initiatives in the regions it serves. Read More
HCA Healthcare (NYSE:HCA) said its second-quarter performance reflected solid demand in several service lines and 11% growth in diluted earnings per share, but the company faced increased financial pressure as patients losing health insurance exchange coverage shifted largely into the uninsured popu
Hospital operator HCA Healthcare (NYSE:HCA) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 8.7% year on year to $20.23...
Hospital operator HCA Healthcare (NYSE:HCA) will be announcing earnings results this Friday morning. Here’s what to expect. HCA Healthcare met analysts’ reve...
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In HCA To Contact Him Directly To Discuss Their Options
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc. securities and experienced significant financial losses.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or “the Company”) (NYSE: HCA) for violations of the securities laws.
Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.
Check out the companies making headlines this week: HCA Healthcare (NYSE:HCA): Hospital operator HCA Healthcare (NYSE:HCA) fell by 6.7% on Tuesday after the ...
What Happened? Shares of hospital operator HCA Healthcare (NYSE:HCA) fell 6.7% in the morning session after the company released preliminary second-quarter r...
HCA Healthcare, Inc. (NYSE: HCA) today announced preliminary financial and operating results for the second quarter ended June 30, 2026. The preliminary financial and operating results are subject to finalization of the Company's quarterly financial and accounting procedures.
Over the past six months, HCA Healthcare’s stock price fell to $423.55. Shareholders have lost 11.6% of their capital, which is disappointing considering the...
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced new research published in The New England Journal of Medicine (NEJM) demonstrating promising results from a gene-editing therapy being investigated in children ages 5-11 with severe sickle cell disease and transfusion-dependent beta thalassemia.
